Can We STEDI the Course? Antimicrobial Value Assessment at a Crossroads

About this session

Issue: Antimicrobial resistance (AMR) represents a critical global health challenge: we urgently need new antibiotics, yet current HTA approaches have become an active barrier to this innovation.

Speakers

• 

  Laith Yakob

  Adelphi Values PROVE

  Moderator

• EB

  Edward I Broughton

  Pfizer

  Panelist

• GH

  Grace Hampson

  Office of Health Economics

  Panelist

• 

  Entela Xoxi

  Independent Consultant

  Panelist